Sentences with phrase «active hepatitis»

Common liver diseases in dogs include infectious canine hepatitis, chronic active hepatitis, Porto - systemic shunt, hepatic microvascular dysplasia, liver fibrosis, copper toxicosis and cancer.

Chronic active hepatitis, also called chronic canine inflammatory hepatic disease, can strike any dog, regardless of gender, breed or age.

Other diseases that can lead to chronic active hepatitis are infectious canine hepatitis, leptospirosis, autoimmune disease and drug and chemical toxicities.

Other health issues in Dobermans include autoimmune hemolytic anemia, immunoglobulin deficiencies, kidney disease, pancreatic insufficiency, liver shunt, and a severe liver disease called chronic active hepatitis.

Chronic active hepatitis is more common in dogs than in cats.

Dogs with chronic active hepatitis have smaller than normal livers.

Hepatic and biliary disease, including hepatic lipidosis, cholangiohepatitis, biliary obstruction, hepatic encephalopathy, chronic active hepatitis

A few go on to suffer chronic renal failure or develop chronic active hepatitis — neither of which is curable.

Term «chronic active hepatitis» refers to the fact that the disease is a long term inflammatory assault to the liver and its cells.

Dogs affected by chronic active hepatitis are predisposed to cirrhosis later in life, but owner compliance in my experience plays a big role in whether or not this will occur.

Hepatic and biliary diseases including lipidosis, acute hepatitis / hepatocellular necrosis, cholangiohepatitis, biliary obstruction, hepatic encephalopathy, chronic active hepatitis.

With the exception of very specific cases of copper accumulation in the liver (specific to only a few breeds) and aflatoxins accumulating from eating moldy corn (also a rare occurrence), the vast majority of case of chronic active hepatitis in dogs are autoimmune in origin.

Once the veterinarian is convinced of a diagnosis of chronic active hepatitis, treatment begins with IV fluids to hydrate the patient and support the liver, antibiotics to treat any potential secondary infections, and a steroid to halt and prevent inflammation.

Chronic active hepatitis is and inflammatory disease of the liver common in small to medium breed dogs, but can occur in any breed of dog, male or female, can occur at any age, although most affected dogs fall in the middle age to senior age range.

The fact that chronic active hepatitis has a higher incidence in certain breeds, suggests an underlying genetic cause.

Bloodwork in cases of chronic active hepatitis usually reveals elevated liver enzymes, elevated total bilirubin, and sometimes an elevated white blood cell count.

Spaniels specifically seem especially predisposed to the development of chronic active hepatitis.

There are several other autoimmune diseases that have been associated with hashimoto thyroiditis such as addison's disease, diabetes mellitus, hyogonadism, pernicious anaemia, alopecia areata, chronic active hepatitis, giant cell arteritis, primary billary cirrhosis, rheumatoid arthritis, vitiligo and others.

Inclusion Criteria: • Availability of tumor tissue for mesothelin expression testing • Histologically - confirmed, mesothelin - expressing metastatic or advanced non-metastatic disease (tumour type specific inclusion criteria) • At least one measurable lesion according to either Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 or International Thymic Malignancy Interest Group (ITMIG) modified RECIST 1.1 as applicable • Adequate bone marrow, liver, renal and coagulation function • Left ventricular ejection fraction (LVEF) ≥ 50 % of the lower limit of normal (LLN) according to local institutional ranges • Eastern Cooperative Oncology Group (ECOG) 0 or 1 Exclusion Criteria: • More than one prior anti - tubulin / microtubule agent • Corneal epitheliopathy or any eye disorder that may predispose the patients to this condition • Symptomatic Central nervous system (CNS) metastases and / or carcinomatous meningitis • Contraindication to both CT and MRI contrast agents • Active hepatitis B or C infection • Pregnant or breast - feeding patients • Tumor type specific exclusion criteria

• Patients must have adequate coagulation (international normalized ratio (INR) or prothrombin time (PT), partial thromboplastin time (PTT) ≤ 1.5 times ULN) • Adequate liver function (total bilirubin ≤ 1.5 times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 times ULN Exclusion Criteria: • Presence of active / uncontrolled central nervous system involvement • History of clinically significant cardiac disease; uncontrolled hypertension • Left ventricular ejection fraction (LVEF) < 45 % • Allogeneic stem cell transplant within 100 days before first dose of study drug • Known history of human immunodeficiency virus (HIV) infection • Chronic or active hepatitis B or C, requiring antiviral therapy • Evidence of history of bleeding disorder, dialysis, or coexisting cancer that is distinct in primary site or histology from the cancer evaluated in this study • Serious, uncontrolled infection • Unresolved chronic toxicity > grade 1 from prior therapy • Use of strong CYP3A4 inhibitors or strong inducers within 7 days prior to the start of study treatment and for the duration of the study

And as we now know, chronic inflammation can cause a host diseases and debilitating conditions, including rheumatoid arthritis, heart disease, digestive disorders (from IBD and IBS to Ulcerative colitis and Crohn's disease), asthma, ulcers, sinusitis, atherosclerosis, periodontitis, hay fever, active hepatitis, diabetes, Alzheimer's and even cancer.

Not exact matches

Dandelion roots and leaves can help improve liver health, especially in the case of hepatitis C. Taraxin, the active compound in dandelion, is a choleretic, which means that it stimulates bile production by the liver.

It has been used to help treat chronic liver disease and hepatitis B and C. Its active component is a compound called silymarin, and like, dandelion, it is a choleretic.

A similar positive results were achieved by a group of scientists who treated patients with hepatitis C virus for six months with either Spirulina or Silymarin (an active ingredient found in Milk thistle) with no negative side effects.